< Zurück zu den aktuellen Neuigkeiten & Events

Veranstaltungen

Manufacturing & Supply Chain Conference 2022

Februar 2022

Veranstaltungsdatum: 10. März 2022

HGF Patent Attorney Dr Robert Weinert-Aplin is attending and speaking at the Manufacturing & Supply Chain Conference on 10th March 2022 in Milton Keynes, UK.

The Manufacturing & Supply Chain Conference is a national forum for manufacturers and operators involved throughout the associated supply chains from across the UK. It is an opportunity to gather to discuss pressing issues facing the industry.

The event will cover various topical themes including: Industry 4.0, Digital Manufacturing, Smart Factory, Lean & Continuous Improvement, Robotics & Automation, Financing Investment, Industrial Blockchain, Research & Development, Precision Engineering, QEHS, Supply Chain & Logistics, Sustainability, Government Policy and Industrial Strategy, Exports and Skills & Training.

Dr Robert Weinert-Aplin will be speaking on ‘Is 3D printing changing the status quo for manufacturers and the supply chain?‘:

Additive manufacturing (AM) has advanced hugely over the last decade, and is benefiting a wider range of industries. Improvements in AM technologies has enabled companies to move from seeing AM solely as a prototyping tool to having AM processes embedded within the manufacturing and supply chains of the final product to provide more sustainable products with shorter lead times that were previously not economically viable. Traditionally, registered intellectual property rights (IPRs), particularly patents, would underpin a company’s decision to invest in new technology to change the status quo. However, the laws related to IPRs have arguably not adapted at the same pace as the technology they aim to protect. While new materials and manufacturing methods specific to AM sit comfortably within the patent system, the Computer-Aided Design (CAD) models which underpin the AM processes are at risk of falling outside the scope of the existing IPR regimes. In this talk, Rob discusses how AM is changing a product’s value chain and how IPRs can be used to protect your investment when incorporating AM processes into manufacturing and supply chains.

Aktuelle Neuigkeiten

The Antibody Series #4 | pH‑Werte in Antikörperansprüchen – wenn „gleicher pH‑Wert“ zur unzulässigen Erweiterung wird

          Die Beschwerdekammern des EPA (BoA) sind die Berufungsinstanz, die Entscheidungen des EPA überprüft. In diesem Fall befassten sie sich mit einer Entscheidung zur Widerrufung eines …

Weiterlesen

The Antibody Series #3 | Codenamen von Antikörpern in Ansprüchen: Warum „ACZ885” nicht ausreicht, um den Antikörper zu definieren

          Die Beschwerdekammern des EPA (BoA) sind die Berufungsinstanz, die Entscheidungen des EPA überprüft. In diesem Fall prüften sie einen Anspruch, der einen Antikörper anhand eines …

Weiterlesen

Agritech Thymes: Unlocking the Soil Microbiome: Driving Agritech Innovation in the UK

The UK offers an ideal platform for harnessing the untapped potential of soil and plant microorganisms. Although much of my professional experience has focused on the human microbiome, I have …

Weiterlesen

The Antibody Series #2 | Definition anhand der Bindungsstärke in Antikörperansprüchen: Wenn „binds strongly … but only minimally …“ zu einer Falle mangelnder Klarheit wird.

            Die Definition eines Antikörpers anhand seiner Bindungsstärke ist in Patentansprüchen gängige Praxis, kann jedoch im Hinblick auf Artikel 84 EPÜ zur Klarheit schnell zu …

Weiterlesen

The Antibody Series #1 | Qualitätsmerkmale (CQAs) in Antikörperansprüchen: Wenn die Testmethode aus dem Anspruch herausgenommen werden kann

            Therapeutische Antikörper stehen im Mittelpunkt der Innovationen in der Biotechnologie und im Gesundheitswesen. Angesichts steigender regulatorischer Anforderungen und Qualitätserwartungen werden kritische Qualitätsmerkmale (CQAs) bei …

Weiterlesen

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Weiterlesen

When Retail Branding Meets Politics

(Inter IKEA Systems v Algemeen Vlaams Belang (Case C‑298/23) In November 2022, the Flemish political party Vlaams Belang presented its “IKEA-PLAN – Immigratie Kan Echt Anders” (“Immigration Really Can Be Different”). …

Weiterlesen

Büro geschlossen – Dezember 2025 / Januar 2026

HGF Büro geschlossen – Dezember 2025 / Januar 2026   UK Donnerstag, 25. und Freitag, 26. Dezember 2025 GESCHLOSSEN Donnerstag, 1. Januar 2026* GESCHLOSSEN * Freitag, 2. Januar 2026 – …

Weiterlesen